135 related articles for article (PubMed ID: 16892030)
1. ALS: life and death in a bad neighborhood.
Monk PN; Shaw PJ
Nat Med; 2006 Aug; 12(8):885-7. PubMed ID: 16892030
[No Abstract] [Full Text] [Related]
2. Onset and progression in inherited ALS determined by motor neurons and microglia.
Boillée S; Yamanaka K; Lobsiger CS; Copeland NG; Jenkins NA; Kassiotis G; Kollias G; Cleveland DW
Science; 2006 Jun; 312(5778):1389-92. PubMed ID: 16741123
[TBL] [Abstract][Full Text] [Related]
3. Mutant mice, Cu,Zn superoxide dismutase, and motor neuron degeneration.
McCord JM
Science; 1994 Dec; 266(5190):1586-7. PubMed ID: 7985031
[No Abstract] [Full Text] [Related]
4. [ALS and microglia--a player for non-cell-autonomous neuron death].
Yamanaka K; Yamashita H
Brain Nerve; 2007 Oct; 59(10):1163-70. PubMed ID: 17969357
[TBL] [Abstract][Full Text] [Related]
5. Amyotrophic lateral sclerosis--are microglia killing motor neurons?
Borchelt DR
N Engl J Med; 2006 Oct; 355(15):1611-3. PubMed ID: 17035656
[No Abstract] [Full Text] [Related]
6. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation.
Koh SH; Kim Y; Kim HY; Cho GW; Kim KS; Kim SH
Eur J Neurosci; 2007 Apr; 25(7):1923-30. PubMed ID: 17439481
[TBL] [Abstract][Full Text] [Related]
8. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading.
Subramaniam JR; Lyons WE; Liu J; Bartnikas TB; Rothstein J; Price DL; Cleveland DW; Gitlin JD; Wong PC
Nat Neurosci; 2002 Apr; 5(4):301-7. PubMed ID: 11889469
[TBL] [Abstract][Full Text] [Related]
9. Increased cytotoxic potential of microglia from ALS-transgenic mice.
Weydt P; Yuen EC; Ransom BR; Möller T
Glia; 2004 Nov; 48(2):179-82. PubMed ID: 15378658
[TBL] [Abstract][Full Text] [Related]
10. The genetic and molecular mechanisms of motor neuron disease.
Wong PC; Rothstein JD; Price DL
Curr Opin Neurobiol; 1998 Dec; 8(6):791-9. PubMed ID: 9914243
[TBL] [Abstract][Full Text] [Related]
11. Activation of microglial neuregulin1 signaling in the corticospinal tracts of ALS patients with upper motor neuron signs.
Song F; Chiang P; Ravits J; Loeb JA
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):77-83. PubMed ID: 24229388
[TBL] [Abstract][Full Text] [Related]
12. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
[TBL] [Abstract][Full Text] [Related]
13. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
Morrison BM; Morrison JH; Gordon JW
J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
[TBL] [Abstract][Full Text] [Related]
14. Pathoetiology of motor neuron disease: new insights from genetics and animal models.
Trounce I; Feeney S; Byrne E
J Clin Neurosci; 2003 May; 10(3):293-6. PubMed ID: 12763330
[No Abstract] [Full Text] [Related]
15. Increase of disease duration of amyotrophic lateral sclerosis in a mouse model by transgenic small interfering RNA.
Yokota T; Sasaguri H; Saito Y; Yamada H; Unno T; Yamamoto Y; Kubodera T; Anzai M; Mitani T; Mizusawa H
Arch Neurol; 2007 Jan; 64(1):145-6. PubMed ID: 17210827
[No Abstract] [Full Text] [Related]
16. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
17. Novel therapeutic targets in neurodegenerative diseases: lessons from amyotrophic lateral sclerosis.
Appel SH; Beers DR; Henkel JS; Zhao W
Curr Neurol Neurosci Rep; 2008 Sep; 8(5):353-5. PubMed ID: 18713569
[No Abstract] [Full Text] [Related]
18. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
19. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
[TBL] [Abstract][Full Text] [Related]
20. Of mice, men and motor neurons.
Newbery HJ; Abbott CM
Trends Genet; 2001 Oct; 17(10):S2-6. PubMed ID: 11585669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
